share_log

Analyst Ratings for Lifecore Biomedical

Analyst Ratings for Lifecore Biomedical

Lifecore 生物医学的分析师评级
Benzinga ·  2023/03/22 01:03

Lifecore Biomedical (NASDAQ:LFCR) has observed the following analyst ratings within the last quarter:

Lifecore Biomedical(纳斯达克股票代码:LFCR)在上个季度观察到以下分析师评级:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 3 1 0 0
Last 30D 0 1 0 0 0
1M Ago 0 2 1 0 0
2M Ago 0 0 0 0 0
3M Ago 0 0 0 0 0
看涨 有点看涨 漠不关心 有点看跌 看跌
评分总数 0 3 1 0 0
最后 30D 0 1 0 0 0
1 个月前 0 2 1 0 0
2 个月前 0 0 0 0 0
3M 之前 0 0 0 0 0

According to 4 analyst offering 12-month price targets in the last 3 months, Lifecore Biomedical has an average price target of $7.25 with a high of $11.00 and a low of $2.00.

根据4位分析师在过去3个月中提供12个月目标股价,Lifecore Biomedicare的平均目标价为7.25美元,最高为11.00美元,低点为2.00美元。

Below is a summary of how these 4 analysts rated Lifecore Biomedical over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

以下是这四位分析师在过去3个月中对Lifecore Biomedicary的评级摘要。看涨评级的数量越多,分析师对该股的看法就越积极,看跌评级的数量越多,分析师对该股的负面评价就越多

This current average has decreased by 29.82% from the previous average price target of $10.33.

目前的平均价格比之前的平均目标价10.33美元下降了29.82%。

Stay up to date on Lifecore Biomedical analyst ratings.

随时了解Lifecore Biomedicary分析师的最新评级。

If you are interested in following small-cap stock news and performance you can start by tracking it here.

如果你有兴趣关注小盘股的新闻和表现,可以先在这里追踪。

How Are Analyst Ratings Determined?

分析师评级是如何确定的?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Benzinga追踪了150家分析公司并报告了他们的股票预期。分析师通常通过预测公司未来(通常是未来五年)将赚多少钱,以及该公司的收入来源的风险或可预测性来得出结论。

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

分析师参加公司电话会议和会议,研究公司财务报表,并与内部人士沟通,公布他们的股票评级。分析师通常每季度对每只股票进行一次评级,或者在公司有重大更新时对每只股票进行一次评级。

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

一些分析师还将提供增长预期、收益和收入等指标的预测,以为股票提供进一步指导。使用分析师评级的投资者应注意,这种专业建议来自人类,可能会出错。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发